Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms

Johannes Uhlig, James Nie, Joanna Gibson, Michael Cecchini, Stacey Stein, Jill Lacy, Pamela Kunz, Hyun S Kim · 2024

Read Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms by Johannes Uhlig, James Nie, Joanna Gibson, Michael Cecchini, Stacey Stein, Jill Lacy, Pamela Kunz, Hyun S Kim (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11652651.txt.

Description

Neuroendocrine tumors of the gut and pancreas are rare, slow, and increasingly found. Johannes Uhlig and seven co-authors chart them in 2024 through the United States national cancer database, following more than eighty-six thousand patients. Annual cases more than doubled between 2004 and 2016, driven by small, early tumors.

Surgery dominated treatment, and operated patients lived longest. Added drug therapy helped most in the highest grade, latest stage cases. Survival also tracked money and coverage: higher income and private insurance or Medicare lengthened life, while Medicaid did not. The authors read the rise as better detection more than more disease. They name access itself as a treatment target.

Catalog record

CREATORJohannes Uhlig, James Nie, Joanna Gibson, Michael Cecchini, Stacey Stein, Jill Lacy, Pamela Kunz, Hyun S Kim
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11652651

Browse the full library · About the Tower of Babel